Outcome of Translarna's Re-evaluation by CHMP in 2024

Will PTC Therapeutics initiate a new phase of clinical trials for Translarna within the next 12 months?

Market Reaction to Final Decision on Translarna's Marketing Authorization

Public and Patient Advocacy Reactions to Final CHMP Decision on Translarna

PTC518 FDA Approval for Huntington's by End of 2025?

Will PTC518 receive FDA approval for Huntington's disease by end of 2025?

Will PTC Therapeutics receive FDA approval for a new gene therapy by December 31, 2024?

Will PTC Therapeutics' AADC gene therapy be approved in the EU by end of 2025?

Will PTC Therapeutics' stock reach a new annual high by the end of 2024?

Will PTC518 enter Phase 3 trials for Huntington's disease by mid-2025?

What will be the total revenue generated for PTC from PTC518 by end of 2025?

Kebilidi commercial availability in the US by March 31, 2025?

What will be the market penetration of Kebilidi in the US by December 31, 2024?

Will PTC Therapeutics' stock price increase by 10% or more by December 31, 2024?

Which company will partner with PTC Therapeutics for Kebilidi by June 30, 2025?

Will PTC Therapeutics' stock price increase by 10% or more by January 31, 2025?

Will PTC Therapeutics' AADC gene therapy reach $100 million in sales by end of 2025?

PTC518 Milestone Payments from Novartis by End of 2025?

PTC518 Global Market Share in First Year Post-Launch?

PTC518 Phase 3 Clinical Trials Start by End of 2024?

Outcome of PTC518 Phase 2 Trials by End of 2024?

Top Sales Region for PTC518 in First Two Years?

How many additional partnerships will PTC form for PTC518 by end of 2025?

Will PTC and Novartis achieve first milestone payment for PTC518 by end of 2024?

What will be PTC518's US market share in Huntington's disease treatments by 2026?

PTC partnership for Kebilidi by end of 2024?

Market price of Kebilidi in the US by June 30, 2025?

Major US insurance coverage for Kebilidi by June 30, 2025?

Number of US patients treated with Kebilidi by end of 2025?

First region to adopt Kebilidi post-US approval by December 31, 2024?

Will Kebilidi gene therapy reach $50 million in sales by March 31, 2025?

In how many countries will Kebilidi be approved by December 31, 2025?

In which major markets will PTC's AADC gene therapy be available by end of 2025?

How many patients will be treated with PTC's AADC gene therapy by end of 2025?

What additional regulatory designations will PTC's AADC gene therapy receive by end of 2025?

PTC Therapeutics' Investment Strategy in Duchenne Muscular Dystrophy Research Over the Next Year